| ISIN | CH0008410448 |
|---|---|
| Valor Number | 841044 |
| Bloomberg Global ID | UBCHFA1 SW |
| Fund Name | VVA - Aktien Schweiz F |
| Fund Provider |
UBS Switzerland AG, Zurich
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS Switzerland AG, Zurich |
| Representative in Switzerland | |
| Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
| Asset Class | Other Funds |
| EFC Category | Equity Switzerland |
| Distribution Policy | Distribution |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 225.57 CHF | 11.12.2025 |
|---|---|---|
| Previous Price * | 225.96 CHF | 10.12.2025 |
| 52 Week High * | 227.98 CHF | 03.03.2025 |
| 52 Week Low * | 189.68 CHF | 09.04.2025 |
| NAV * | 225.57 CHF | 11.12.2025 |
| Issue Price * | 225.57 CHF | 11.12.2025 |
| Redemption Price * | 225.57 CHF | 11.12.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 1,209,413,445 | |
| Unit/Share Assets *** | 1,209,413,445 | |
| Trading Information SIX | ||
| YTD Performance | +12.14% |
31.12.2024 - 11.12.2025
31.12.2024 11.12.2025 |
|---|---|---|
| 1 month | +1.24% |
11.11.2025 - 11.12.2025
11.11.2025 11.12.2025 |
| 3 months | +4.58% |
11.09.2025 - 11.12.2025
11.09.2025 11.12.2025 |
| 6 months | +3.45% |
11.06.2025 - 11.12.2025
11.06.2025 11.12.2025 |
| 1 year | +11.13% |
11.12.2024 - 11.12.2025
11.12.2024 11.12.2025 |
| 2 years | +19.45% |
11.12.2023 - 11.12.2025
11.12.2023 11.12.2025 |
| 3 years | +22.38% |
12.12.2022 - 11.12.2025
12.12.2022 11.12.2025 |
| 5 years | +35.06% |
11.12.2020 - 11.12.2025
11.12.2020 11.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Novartis AG Registered Shares | 13.41% | |
|---|---|---|
| Nestle SA | 13.04% | |
| Roche Holding AG | 12.24% | |
| Zurich Insurance Group AG | 7.63% | |
| ABB Ltd | 7.38% | |
| Compagnie Financiere Richemont SA Class A | 5.23% | |
| Swiss Re AG | 3.89% | |
| Holcim Ltd | 3.54% | |
| Alcon Inc | 3.12% | |
| Lonza Group Ltd | 2.82% | |
| Last data update | 31.10.2025 | |
| TER | 0.50% |
|---|---|
| TER date | 30.09.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.50% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 30.11.2025 |